−£39k
vs Mar 2024Active13308088Private limited companyBristol
NEUROCHASE TECHNOLOGIES LTD
Significant control: Neurochase Holdings Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Neurochase Technologies Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Neurochase Technologies Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEUROCHASE TECHNOLOGIES LTD is an active private limited company (company number 13308088) incorporated on 1 April 2021, registered in Bristol. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£39k and cash of £8,534, with 3 employees on average. Net assets fell 60% on the prior period (−£24k).
Peer position · net assets
By net assets it sits in the bottom quarter of 50 comparable companies in Bristol (median £17k, upper quartile £164k).
02
Ownership and control
- Neurochase Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Prof Steven Streatfield Gill
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 1 April 20215 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 15 April 2027in 173 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£8,534
+10%vs Mar 2024Not reported
3
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£39k | £8,534 | £3,737 | — | — | — | 3 |
| 31 March 2024 | −£24k | £7,732 | £13k | — | — | — | 3 |
Cash per employee£2,845Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-39,049 at 31 March 2025
- Net assets down 25% or more on the prior period-59.6% vs prior period
- Incorporated five or more years agoIncorporated 1 April 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 173 days
- Next accounts duein 68 days
- Accounts period endNet liabilities £39k · small accounts
- Accounts period endNet liabilities £24k · small accounts
- Incorporated
08
Similar companies in Bristol
- CDOTBIO LIMITEDBristol · inc. Apr 2021
- NEW EARTH DEVELOPMENTS LTDBristol · inc. Dec 2020
- SCARLET THERAPEUTICS LIMITEDBristol · inc. Jul 2021
- ANTHONI CT PARTNERS LIMITEDBath · inc. Nov 2020
- TRANSDERMAL DIAGNOSTICS LTDBristol · inc. Aug 2021
- SCALE DX LTDBristol · inc. May 2020
All companies incorporated on 1 April 2021 · in Apr 2021.
09
Reminders for NEUROCHASE TECHNOLOGIES LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.